Science Hub is Novo Nordisk’s one-stop portal for all our scientific publications and clinical trials, congress materials and medical updates. Sign up to gain full access.
Semaglutide demonstrates efficacy in improving liver fibrosis across diverse subpopulations in part 1 of the ESSENCE trial outcomes in Asian and non-Asian populations
Authors:
Jacob George 1; Atsushi Nakajima 2; Chun-Jen Liu 3; Won Kim 4; George Boon Bee Goh 5; Jidong Jia 6; Kwabena Opuni 7; Niels Krarup 7; Mette Skalshøi Kjær 7; Anna Maria Bartyzel 7 & Arun J. Sanyal 8.